The PRIME Registry is a multi-center, observational study designed to evaluate immediate and long-term outcomes (36 months) of endovascular revascularization in patients with critical limb ischemia (CLI) and advanced peripheral artery disease (PAD).
The Peripheral RegIstry of Endovascular Clinical OutcoMEs (PRIME Registry) represents the collaborative effort among seven centers across the US with the goal of reaching 10 sites globally. PRIME explores all aspects of advanced peripheral arterial disease (PAD) and critical limb ischemia (CLI) care including the collection of comprehensive clinical, diagnostic, procedural, and follow-up data for three years following an index endovascular procedure. Data collection activities began in January of 2013 with the goal of collecting data on 1500 subjects. Analysis of this multi-site registry will produce generalizable findings that describe the clinical epidemiology and management practices of advanced PAD and CLI patients.
Study Type
OBSERVATIONAL
Enrollment
1,000
Orlando Health
Orlando, Florida, United States
Prairie Heart
Springfield, Illinois, United States
Metro Health Hospital
Wyoming, Michigan, United States
Cox Health
Springfield, Missouri, United States
Amputation free survival rates
Time frame: At 36 month follow-up visit
Access site and procedural complications
Time frame: At 36 month follow-up visit
Target lesion revascularization
Time frame: At 36 month follow-up visit
Target vessel revascularization
Time frame: At 36 month follow-up visit
Procedural success
Time frame: At 36 month follow-up visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Rex Healthcare
Raleigh, North Carolina, United States
The Hospitals of Providence
El Paso, Texas, United States